Background
==========

Glaucoma is the leading irreversible eye disease in the world. The number of glaucoma patients will exceed 76 million by 2020, among which over 11 million will be bilaterally blind \[[@b1-medscimonit-24-1988],[@b2-medscimonit-24-1988]\]. Elevation of intraocular pressure (IOP) is regarded the most important risk factor for the development of glaucoma, and IOP control is for now the only effective and well-accepted treatment. However, approximately 30% of glaucoma patients present without elevation of IOP \[[@b3-medscimonit-24-1988]--[@b5-medscimonit-24-1988]\]. Over 90% of Japanese open-angle glaucoma patients have normal IOP \[[@b6-medscimonit-24-1988]\]. The Baltimore Eye Survey revealed that 20% of their POAG patients had an IOP of less than 21 mmHg on each of their first 3 visits, suggesting that normal-pressure eye disease may be more common than previously thought \[[@b3-medscimonit-24-1988]\]. The efficacy of IOP control in normal-pressure glaucoma patients (NPG) has been reported; however, progression is still observed in many cases after lowering IOP. The existence of NPG patients has spurred further research to explore other possible risk factors for glaucoma to find effective treatments \[[@b7-medscimonit-24-1988]\].

Accumulating evidence shows that heat-shock protein (HSP) 60-related autoimmunity is involved in many diseases, including inflammatory arthritis, type 1 diabetes, and multiple sclerosis \[[@b8-medscimonit-24-1988]--[@b10-medscimonit-24-1988]\], as well as in the development of NPG. Higher levels of HSP60 and its antibody have been found in the retina and serum/aqueous fluid of NPG patients, indicating involvement of HSP60-specific autoimmune activity \[[@b11-medscimonit-24-1988]--[@b14-medscimonit-24-1988]\]. Investigation of the association between involvement of HSP autoimmune activity and the signature event of glaucoma, which is retinal ganglion cell (RGC) loss, shows that HSP antibody can lead to changes in regulatory proteins and cytoskeleton of RGCs \[[@b15-medscimonit-24-1988]\]. Furthermore, an experimental autoimmune glaucoma model has been successfully established and demonstrated that immunization with HSP60 can induce upregulated HSP60 antibody and significant RGC loss \[[@b16-medscimonit-24-1988],[@b17-medscimonit-24-1988]\]. Although HSP60-specific autoimmune activity was observed in POAG and NPG, some findings suggest that the ways in which HSP autoimmunity is involved differ between POAG and NPG. Approximately 30% of patients with NPG have 1 or more immune-related diseases, which is not observed in POAG \[[@b18-medscimonit-24-1988]\]. Unlike NPG, progression is limited in most cases of POAG if IOP is under control. More importantly, a higher titer of autoantibody to HSP60 was mainly found in patients with normal-pressure glaucoma, and less or no significant difference was found between POAG and control subjects in some studies \[[@b19-medscimonit-24-1988]\].

Balanced responses of both pro- and anti-inflammatory Th cells are essential to prevent an immune response from turning into autoimmune disease. Recently, imbalances have been reported to be responsible for some autoimmune diseases, such as multiple sclerosis and type 1 diabetes, which are also associated with HSP60 \[[@b20-medscimonit-24-1988],[@b21-medscimonit-24-1988]\]. Therefore, in this study, after evaluating the levels of HSP60 and its antibody in our POAG and NPG patients, we evaluated the percentages of the main Th cells involved in pro-inflammatory and anti-inflammatory responses, attempting to explain the discrepancy with regard to the presence of HSP60 and higher titers of HSP60 antibody in NPG patients compared to POAG patients.

Material and Methods
====================

Study participants
------------------

This study was approved by the Institutional Review Board of our hospital, and carried out in accordance with the Declaration of Helsinki. After obtaining written informed consent, peripheral blood was collected from each participant, including glaucomatous patients and healthy volunteers.

Consecutive patients with POAG and NPG visiting Shanghai Ninth People's Hospital between October 2013 and April 2015 were considered for inclusion in this study. Patients were followed clinically by one of the authors for a minimum of 2 years and received ophthalmologic examinations at least 4 times yearly.

The inclusion criteria for POAG consists of the presence of open iridocorneal angles, IOP higher than 21 mmHg, characteristically glaucomatous changes in visual fields, optic nerve cupping, retinal nerve fiber layer thinning, and the absence of other possible causes of optic neuropathy. Inclusion criteria for NPG are the same as for POAG except that no evidence showed IOP exceeded 21 mmHg, confirmed at least twice by 24-h IOP measurements. Normal control subjects had neither glaucoma nor any other ocular disease.

Exclusion criteria for the POAG and NPG candidates included: a history of any other ocular disease; use of contact lenses; ophthalmic surgical procedures or intraocular laser surgery in the past 1 year before this study; and a history of any kind of immunologic disease and immune-mediated disorder, including inflammation within the last 6 months, and cancer. Exclusion criteria for the NC group were the same as for the other 2 groups.

We screened 174 patients with POAG or NPG, as well as 40 healthy volunteers, during the study period. All candidates underwent thorough ocular examinations, including visual acuity, slit-lamp biomicroscopy, ophthalmoscopy, Goldmann applanation tonometry, visual field testing, and optical coherence topography. Results of examinations of the more severe eye were included in the comparison if both eyes were diagnosed as having glaucoma.

Blood sampling
--------------

We collected 6 mL of fresh peripheral blood into Vacutainer tubes (Becton Dickinson Systems, San Jose, CA) containing EDTA from each participant. After serum was isolated and stored at −80°, peripheral blood mononuclear cells (PBMCs) were isolated with the Ficoll-Hypaque density gradient (density 1.077; Biochrom, Berlin, Germany) centrifugation method. Isolated PBMCs were then resuspended in RPMI 1640 medium (Gibco, Grand Island, NY) that contained 2 mmol/L L-glutamine, 1 mmol/L sodium pyruvate, 100 μg/mL streptomycin, 100 units/mL penicillin, and 10% heat-inactivated fetal bovine serum.

Cell culture and stimulation
----------------------------

Isolated PBMCs were plated at a density of 1.0×10^6^/well and cultured in the absence or presence of HSP60 (2.5 ng/ml, Enzo Life Sciences Inc., Farmingdale, NY) for 2 days. Cells were cultured and harvested for flow cytometry for a direct culture assay as described by Kepitein and de Kleer \[[@b22-medscimonit-24-1988],[@b23-medscimonit-24-1988]\], in which the peripheral blood monocytes were isolated and cultured with or without the stimulation of HSP60, and at different time points of culture, monocytes were collected for flow cytometry analysis.

Flow cytometry
--------------

Prior to Th1, Th2, and Th17 analysis, cells were first stimulated for 5 h with a cell stimulation cocktail, which included protein transport inhibitors Phorbol 12-myristate 13-acetate (PMA), ionomycin, Brefeldin A, and monensin (eBioscience, San Diego, CA), according to the manufacturer's protocol. Then, cells were extracellularly stained with anti-human CD4 antibody, consecutively fixed and permeabilized (BD Biosciences, San Jose, CA, USA), and intracellularly stained with anti-human interferon-γ, interleukin (IL)-4, and IL-17 antibody (eBioscience, San Diego, CA). For Tregs analysis, no stimulation with cell stimulation cocktail was needed. Monoclonal antibodies (mAbs) specific for anti-human CD4 and CD25 were used for surface staining, and anti-human FoxP3 antibody (eBioscience, San Diego, CA) was used for intracellular staining after fixation and permeabilization (eBioscience, San Diego, CA). Data were acquired using a FACS Calibur system (BD Biosciences) and analyzed by FlowJo software (Tree Star, Inc.).

Enzyme-linked immunosorbent assay
---------------------------------

Serum HSP60 antibody titers were measured using an in-house enzyme-linked immunosorbent assay (ELISA) described by Ghayour-Mobarhan \[[@b23-medscimonit-24-1988]\]. Briefly, 96-well micro-titer plates (Costar, Corning, NY) were coated with 100 ng per well of low-endotoxin recombinant human HSP60 (Enzo Life Sciences Inc., Farmingdale, NY) dissolved in 100 μl carbonate buffer, and incubated overnight at 4°C under humidified conditions. The wells were then washed 3 times with phosphate-buffered saline (PBS) containing 0.05% Tween-20 (PBST). Non-specific binding was reduced by blocking each well with 10% normal goat serum in PBS, and 200 μl was added to each well, and incubated overnight at 4°C under humidified conditions. Wells were washed 3 times with PBS. Serum was diluted 1: 30 with 1% goat serum in PBS, and 100 μl was added to the each well in duplicate and then incubated for 2 h at room temperature. After washing 3 times in PBST, 100 μl peroxide conjugated-goat anti-human IgG (BD Biosciences, San Jose, CA) diluted 1: 5000 with 1% goat serum in PBS was added to each well and incubated for 45 min at room temperature. After washing 3 times in PBST and 2 times in PBS, 100 μl of tetramethylbenzidine (TMB) substrate (100 μl of 6 mg/ml TMB in DMSO was added to 10 ml of 50 mM acetate buffer, pH 4.5) was added per well, and the plates were incubated for 10 min in the dark at room temperature. Then, 100 ml 2M H~2~SO~4~ was added to each well to stop the reaction. Optical density values were read at 450 nm as a reference length.

Serum levels of cytokines, including IFN-γ, IL-4, IL-10, IL-17, and TGF-β1, were measured with ELISA kits (eBioscience, San Diego, CA) according to the manufacturer's protocols.

Statistical analysis
--------------------

Analyses were performed using SPSS software (version 17.0, SPSS, Chicago, IL). The differences in the results of ophthalmic examinations between POAG and NPG groups were calculated using the*t* test, signed-rank test, or chi-square test. One-way analysis of variance with Bonferroni post hoc analysis was used when comparing results of ELISA and flow cytometry. P values \<0.05 were considered statistically significant.

Results
=======

Subjects
--------

Finally, 35 patients were included in the POAG group, 19 patients in the NPG group, and 27 normal participants in the NC group. Demographic and clinical information of patients is shown in [Table 1](#t1-medscimonit-24-1988){ref-type="table"}. All 3 groups are age- and sex-matched.

Higher antibody titers were found in NPG group
----------------------------------------------

Controversial results have been obtained in different studies with regard to the level of HSP60 antibody in POAG, suggesting the HSP60 antibody level might vary in different groups of POAG patients. Therefore, we tested the HSP60 antibody level in our patients and based the subsequent analysis on the results. The titer of anti-HSP60 antibody was measured using an in-house ELISA within 1 week after the serum was collected and stored at −80°. Serum titer of anti-HSP60 antibody was significantly higher in NPG patients than in POAG patients or normal participants ([Figure 1](#f1-medscimonit-24-1988){ref-type="fig"}), indicating that in these 3 groups of subjects, higher level of anti-HSP60 was mainly found in NPG, and anti-HSP60 level was not higher in POAG, compared to normal controls.

Imbalance between pro- and anti-inflammatory responses of Th cells in POAG and NPG
----------------------------------------------------------------------------------

It has been confirmed by previous reports that elevated expression of HSP60 was found in retinas of both POAG and NPG patients, which means both group of patients were exposed to the antigen HSP60. Since we also observed in our patients that the anti-HSP60 level was only higher in the NPG group, we hypothesized that after the exposure to HSP60, different immune events in POAG and NPG may occur and lead to differences in antibody reactivity. Imbalance between pro- and anti-inflammatory responses of Th cells is associated with HSP60-related autoimmune diseases, so we evaluated the frequencies of Th cells and levels of related cytokines.

Circulating pro-inflammatory Th cell frequencies
------------------------------------------------

Th2 frequency was increased in both POAG and NPG patients.

The proportion of Th2 cells is expressed as the percentage of all CD4+ T cells. The frequency of Th2 cells was evidently increased in the peripheral blood of patients in the POAG and NPG groups compared to the NC group (POAG group: 0.849±0.299; NPG group: 0.726±0.227; NC group: 0.507±0.18; p=0.000; [Figure 2](#f2-medscimonit-24-1988){ref-type="fig"}). No significant difference was found between the POAG and NPG group (p\>0.05).

Th1 frequency was decreased in POAG patients
--------------------------------------------

Unlike Th2 cells, Th1 cells are pertinent to cell immunity. Cytokines secreted by Th2 cells can suppress the proliferation of Th1 cells. Compared to the other 2 groups, the frequency of Th1 cells was obviously decreased in the POAG group (POAG group: 11.95±4.5; NPG group: 16.13±6.41; NC group: 17.53±6.89; p=0.001; [Figure 2](#f2-medscimonit-24-1988){ref-type="fig"}). Although the frequency of Th1 cells was lower in the NPG group than in the NC group, no significant difference was observed (p\>0.05).

No obvious difference in frequency of Th17 was observed between groups
----------------------------------------------------------------------

Th17 cells are an important pro-inflammatory component and have been shown to promote inflammation in some diseases. The proportion of Th17 cells is expressed as the percentage of CD4+ T cells. The frequency of Th17 cells was higher in the POAG group compared to that in the other groups, but the difference was not statistically significant (POAG group: 3.04±1.01; NPG group: 2.71±1.07; NC group: 2.82±1.65; p=0.624; [Figure 2](#f2-medscimonit-24-1988){ref-type="fig"}).

Circulating anti-inflammatory Th cells frequencies
--------------------------------------------------

Frequency of Treg cells is expressed as CD25^+^Foxp3^+^ T cells of all CD4^+^ T cells. As shown in [Figure 2](#f2-medscimonit-24-1988){ref-type="fig"}, distinctly increased frequency of Treg was only observed in the POAG group, compared to that in the NC group (POAG group: 9.1±2.48; NPG group: 6.29±1.74; NC group: 6.53±1.7; p=0.000; [Figure 2](#f2-medscimonit-24-1988){ref-type="fig"}). No significant difference was found between the NPG group and NC group (p\>0.05)

Serum levels of pro-inflammatory and anti-inflammatory cytokines
----------------------------------------------------------------

Th1 cells are characterized by the production and release of interferon gamma (IFN-γ). The levels of IFN-γ in the POAG group (24.96±1.94 pg/ml, p\<0.05, [Figure 1](#f1-medscimonit-24-1988){ref-type="fig"}) and the NPG group (24.65±1.50 pg/ml, p\<0.05) were lower than in the NC group (27.33±1.98 pg/ml). Interleukin 4 is the signature cytokine of Th2 cells. The levels of IL-4 were higher in the POAG group (15.59±0.87 pg/ml, p\>0.05) and especially in the NPG group (16.23±0.91 pg/ml, p\<0.05), compared to that in the NC group (14.87±2.30 pg/ml). The level of IL-17A in the POAG group was lower than in the NC group (13.17±1.10 pg/ml *vs.* 14.55±1.98 pg/ml, p\<0.05), and no significant decrease was observed in the NPG group (13.52±1.08 pg/ml). The level of Treg-related cytokines TGF-β1 was higher in the POAG group (5.83±1.93 ng/ml) and NPG group (5.21±1.13ng/ml) compared to the NC group (3.33±0.59 pg/ml). No significant difference was found in the level of IL-10 among groups (3.10±0.75 pg/ml, 3.05±0.62 pg/ml, 3.03±0.55 pg/ml, p\>0.05).

HSP60-induced changes of Th cell frequencies in NPG were different from those in POAG and NC
--------------------------------------------------------------------------------------------

Higher titer of anti-HSP60 was observed only in NPG patients, which supports the presence of HSP60 as an antigen in NPG. We also observed the different pro- and anti-inflammatory Th cell response patterns in POAG and NPG patients. However, it was still unknown whether the presence of HSP60 was associated with the different Th cell patterns or if they were merely coexisting in glaucoma patients. Therefore, we stimulated PBMCs isolated from patients and normal participants with HSP60 for 2 days to observe whether HSP60 would result in Th cell response patterns similar to those we had found previously. Frequencies of Th1, Th2, and Treg cells with or without the stimulation of HSP60 are shown in [Figure 3](#f3-medscimonit-24-1988){ref-type="fig"}. The frequencies of Th2 cells increased more significantly with the stimulation of HSP60 in POAG, NPG, and NC groups than without HSP60 stimulation (1.89±0.34 *vs.* 1.63±0.36, p=0.001; 1.90±0.50 *vs.* 1.71±0.47, p=0.007; 1.59±0.17 *vs.* 1.38±0.20, p=0.001). The frequencies of Th1 cells were lower with the stimulation of HSP60 in POAG, NPG, and NC groups (3.98±0.85 *vs.* 4.44±1.02, p=0.028; 5.29±1.89 *vs.* 5.61±2.00, p=0.02; 4.79±1.69 *vs.* 5.14±1.46, p=0.021). However, more significantly increased frequencies of Treg cells after stimulation of HSP60 were only observed in the POAG and NC groups (12.51±1.78 *vs.* 12.05±1.49, p=0.02; 10.47±2.28 *vs.* 9.81±2.24, p=0.012). In the NPG group, no significant difference in the frequencies of Treg cells was observed with or without the stimulation of HSP60 (8.52±1.19 *vs.* 8.17±1.38, p=0.055), and no significant elevation was observed between basic Treg cell frequency and the frequency after 2-day culture with HSP60 stimulation (8.37±1.18 *vs.* 8.52±1.19, p=0.485).

Discussion
==========

Accumulating evidence on immune response to HSP has been found in glaucoma patients and animal models. Investigations into the immune pathogenesis may increase the probability of finding additional treatments for NPG patients. In 1998, Tezel et al. found increased titers of serum antibodies to HSP60 mainly in NPG patients \[[@b19-medscimonit-24-1988]\]. In the present study, similar results were obtained, showing that titers of anti-HSP60 were also higher in the NPG group compared to the NC group, and no significant difference was observed between the POAG and NC groups. It has been reported that greater intensity of immunostaining and more labeled cells for HSP60 were found in postmortem eyes of POAG and NPG patients \[[@b11-medscimonit-24-1988],[@b24-medscimonit-24-1988]\]. If they were exposed to the same antigen, why were elevated titers of anti-HSP60 found only in the NPG patients?

When confronted with antigens like HSP60, Th cells can differentiate into various subpopulations of T cells with specific functions and properties, including pro- and anti-inflammatory Th cell subsets. Th1 and Th2 cells are 2 kinds of traditional pro-inflammatory Th cells. Th1 cells are characterized by the production and release of IFN-γ and are involved in cellular immune response. Th2 cells are mostly involved in humoral immune response and help B cells to produce antibodies. Recently, Th17 cells were recognized as a novel subset of pro-inflammatory Th cells, providing protection against bacterial infection. In contrast, Treg cells play an important anti-inflammatory role in maintaining the peripheral tolerance, controlled by transcription factor Foxp3 and differentiated in response to TGF-β \[[@b25-medscimonit-24-1988]\]. Balanced function of pro- and anti-inflammatory components is essential to ensure that the immune response is kept under tight control and the chance of developing immunopathy is diminished. The imbalance has been found to be a pathogenic mechanism leading to the onset of autoimmune phenomena, and the abnormal activation of pro-inflammatory cells may be associated with deficiencies in the anti-inflammatory components \[[@b26-medscimonit-24-1988],[@b27-medscimonit-24-1988]\].

In our study, significantly activated pro-inflammatory responses were observed in the POAG and NPG groups, compared to the NC group. Frequencies of Th2 cells were elevated in the POAG and NPG groups, indicating the existence of Th2-driven immune response. However, frequencies of Th1 cells were lower in both groups than in normal controls. The transcription factors of Th2 and Th1 cells -- GATA-3 and T-bet -- are characterized by mutual antagonism, and the production of IL-4 by Th2 antagonizes Th1 polarization. Therefore, decreased Th1 frequency may also support the activation of Th2-driven immune response. Consistently, higher levels of IL-4 and lower levels of IFN-γ were found in both glaucoma groups. However, significantly increased frequency of the anti-inflammatory component -- Treg cells -- was only found in the POAG group, and no significant difference was observed between the NPG and NC groups. The importance of Treg cells in the suppression of potentially harmful and excessive immune responses has been established by many investigations \[[@b28-medscimonit-24-1988]\], and Treg alterations have been identified in several autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus \[[@b29-medscimonit-24-1988]--[@b31-medscimonit-24-1988]\]. It has been reported that Th2 cell-driven immune responses are suppressed by Treg cells via a CK2-controlled mechanisms or IRF4-controlled mechanisms \[[@b32-medscimonit-24-1988],[@b33-medscimonit-24-1988]\]. The lack of increased Treg frequency in the NPG group were observed together with increased Th2 frequency and higher titers of anti-HSP antibodies, implying that the lack of suppression by Treg cells may be ascribed to the increased Th2 cell-driven immune response and consequent RGC apoptosis.

The increased Th2 frequency with decreased Th1 frequency in our study is evidence of weakly immunogenic conditions, because weak antigenic stimulation upregulates expression of a transcription factor GATA-3, which in turn drives differentiation of naïve T cells into Th2 effectors. Although Treg cells usually exert their influence by suppressing the proliferation and cytokine production of effector T cells, under steady-state or weakly immunogenic conditions, Treg cells act principally to inhibit effector function, whereas priming and effector differentiation appears to be unaltered \[[@b34-medscimonit-24-1988],[@b35-medscimonit-24-1988]\]. This may explain why an increased Th2 frequency without elevated IL-4 was found in the peripheral blood of patients in the POAG group. When we evaluated Treg-related cytokines -- TGF-β1 and IL-10 -- the levels of these 2 cytokines were not consistent with the alteration in frequencies of Treg cells. TGF-β1 is a very important suppressive cytokine secreted by Treg cells and can induce Foxp3 expression and a Treg phenotype; however, the serum level of TGF-β1 can be influenced by many other factors. Konstas reported that latanoprost monotherapy has a marked effect on the aqueous concentration of TGF-β1 \[[@b36-medscimonit-24-1988]\]. Kuchtey et al. recently reported the significant elevation of systemic TGF-β1 in POAG patients as compared to controls \[[@b37-medscimonit-24-1988]\], which was also confirmed in our study. Microfibril deficiencies are associated with increased TGF-β signaling and higher systemic TGF-β1 concentrations \[[@b38-medscimonit-24-1988],[@b39-medscimonit-24-1988]\], and microfibril genes are reported to be associated with glaucoma \[[@b40-medscimonit-24-1988],[@b41-medscimonit-24-1988]\], so we hypothesized that the microfibril defects lead to elevation of IOP TGF-β1 in glaucoma patients. Microfibrils are found in the trabecular meshwork, the inner wall of Schlemm's canal, the iris, the ciliary body, and in the optic nerve head \[[@b42-medscimonit-24-1988],[@b43-medscimonit-24-1988]\]. Thus, the microfibril defects may cause elevation of TGF-β1 in both POAG and NPG. The fact that no difference in IL-10 level was observed between groups may show that IL-10-secreting CD4+ Treg cells are not the primary functioning Treg cells in glaucoma patients.

To further investigate if the pattern of pro- and anti-inflammation Th cells was associated with HSP60, we cultured PBMC isolated from POAG and NPG patients and normal participants, with or without the stimulation of HSP60 for 2 days. More significantly elevated Th2 frequencies were observed with the stimulation of HSP60 in all glaucoma patients and normal participants. However, in NPG patients, the frequency of Treg cells was not obviously elevated after 2 days, with or without the HSP60 stimulation, and the Treg cell frequency even decreased in 2 patients. Zhou and Dominguez reported that the frequency of Treg cells increased because HSP60 can induce Treg cells \[[@b44-medscimonit-24-1988],[@b45-medscimonit-24-1988]\]. Therefore, our results indicate that HSP60 can induce Th cell patterns similar to those we had earlier observed in glaucoma patients and normal participants. More importantly, in our study, the absence of increased frequency of Treg cells shows that Treg deficiency might exist in NPG patients. This deficiency might lead to an imbalance between pro- and anti-inflammatory components, which could consequently cause the activation of Th2-driven immune response and elevated titers of anti-HSP60 in NPG patients. Efforts have been made to investigate Treg-inducing adjuvant, which may be a potential treatment for some NPG patients.

There are 2 main limitations to our study. First, more samples are needed to determine whether Treg deficiency exists only in the minority of NPG patients or in most of them. Second, *in vivo* experiments with animal models are needed to determine whether the absence of activated and functional Treg will cause NPG-like immune response and RGC loss. Further elucidation of the role of immune responses in glaucoma will inspire the discovery of novel pathogenic mechanism and even diagnostic and therapeutic strategies in glaucoma.

Conclusions
===========

Different Th cell patterns were observed among POAG, NPG, and NC groups. Lack of induction of Treg cells and imbalance of the pro-inflammatory and anti-inflammatory response patterns of Th cells exist at least in some NPG patients.
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![Comparison of serum levels of anti-HSP60, IFN-γ, IL-4, IL-17A, TGF-β1, and IL-10 between the primary open-angle glaucoma (POAG) group, the normal-pressure glaucoma (NPG) group, and the normal control (NC) group. (**A**) The absorbance of anti-HSP60 was higher in the NPG group than in the NC group (*P*\<0.05). No significant difference was found between the POAG and NC groups. (**B**) Serum levels of IFN-γ were lower in the POAG and NPG groups (*P*\<0.05). (**C**) The levels of IL-17A were lower in the POAG and NPG groups, and the difference was significant between POAG and NC groups (*P*\<0.05). (**D**) Serum level of IL-4 was significant higher in the NPG group than in the NC group (*P*\<0.05). The elevation of IL-4 was not significant in the POAG group compared to the NC group (*P*\>0.05). (**E**) The levels of TGF-β1 were significantly higher in the POAG and NPG groups (*P*\<0.05). (**F**) No significant difference in IL-10 level was observed between groups. Dark blue column: POAG group; light blue column: NPG group; white column: NC group. Statistical significance was analyzed using the *t* test. \* *P* \<0.05.](medscimonit-24-1988-g001){#f1-medscimonit-24-1988}

![Comparison of peripheral frequencies of Th1 (CD4^+^IFN-γ^+^ T cells), Th2 (CD4^+^IL-4^+^ T cells), Th17 (CD4^+^IL-17A^+^ T cells), and Treg (CD4^+^CD25^+^Foxp3^+^ T cells) between the primary open-angle glaucoma (POAG) group, the normal-pressure glaucoma (NPG) group, and the normal control (NC) group. (**A--D**) Representative experiments of the frequencies of Th1 and Th17 cells and comparison between groups. Frequencies of Th1 cells were lower in the POAG and NPG groups compared to the NC group. The difference was significant between the POAG and NC groups (*P*\<0.05). No significant difference in the frequencies of Th17 cells was observed between groups. (**E--H**) Representative experiments on the frequencies of Th2 cells and comparison between groups. Frequencies of Th2 cells were significantly higher in the POAG and NPG groups compared to the NC group (*P*\<0.05). (**I--L**) Representative experiments on the frequencies of Treg cells and comparison between groups. The frequency of Treg cells was higher in the POAG group (*P*\<0.05) but not in the NPG group, compared to the NC group. Dark blue column: POAG group; Light blue column: NPG group; whitr column: NC group. Statistical significance was analyzed using the *t* test. \* *P*\<0.05.](medscimonit-24-1988-g002){#f2-medscimonit-24-1988}

![Frequencies of Th1(CD4^+^IFN-γ^+^ T cells), Th2 (CD4^+^IL-4^+^ T cells), and Treg (CD4^+^CD25^+^Foxp3^+^ T cells) cultured for 2 days with or without the stimulation of HSP60. (**A, D**) Frequencies of Treg cells increased more with the stimulation of HSP60 in primary open-angle glaucoma patients and normal subjects. In normal-pressure glaucoma patients, no significant increase of Treg cells was found after 2-day culture with or without HSP60 stimulation. (**B, E**) Frequencies of Th2 cells increased more significantly with the stimulation of HSP60 in all groups. (**C, F**) Frequencies of Th1 cells decreased more significantly with the stimulation of HSP60 in all groups. POAG -- primary open-angle glaucoma; NPG -- normal-pressure glaucoma; NC -- normal control. Dark blue column: basic Th cell frequency; light blue column: Th cell frequency on day 2, without HSP60 stimulation; white column: Th cell frequency on day 2, with HSP60 stimulation. Statistical significance was analyzed using a paired *t* test or signed-rank test (n=6). \* *P*\<0.05.](medscimonit-24-1988-g003){#f3-medscimonit-24-1988}

###### 

Comparison of demographic and clinical data of POAG and NPG patients.

                                 POAG (n=35)      NPG (n=19)       p-Value
  ------------------------------ ---------------- ---------------- ---------------------------------------------------------------
  Gender (Male: Female)          26: 9            14: 5            0.962[\*](#tfn1-medscimonit-24-1988){ref-type="table-fn"}
  Age (years)                    41.23±11.42      45.89±9.28       0.133[\*\*](#tfn2-medscimonit-24-1988){ref-type="table-fn"}
  Use of prostaglandin analogs   33 (94.29%)      16 (84.21%)      0.227[\*](#tfn1-medscimonit-24-1988){ref-type="table-fn"}
  IOP (mmHg)                     18 (16--22)      15 (14--17)      0.002[\*\*\*](#tfn3-medscimonit-24-1988){ref-type="table-fn"}
  C/D ratio                      0.9 (0.8--0.9)   0.8 (0.8--0.9)   0.970[\*\*\*](#tfn3-medscimonit-24-1988){ref-type="table-fn"}

Chi-square test;

Student's t-test, data are expressed as means and standard deviations;

Wilcoxon rank sum test, data are expressed as medians and interquartile ranges;

POAG -- primary open angle glaucoma; NPG -- normal pressure glaucoma; IOP -- intraocular pressure; C/D ratio -- cup-to-disc ratio.
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